Dietary supplements and a behavior modification plan improve the safety and efficacy of pharmacotherapy

被引:0
|
作者
Kaats, GR [1 ]
Keith, SC [1 ]
Croft, HA [1 ]
Pullin, D [1 ]
Squires, W [1 ]
Wise, JA [1 ]
机构
[1] Hlth & Med Res Fdn, San Antonio, TX 78209 USA
关键词
glyconutritionals; DEXA; body composition; weight loss; fat-free mass;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In both clinical and research settings, evaluation of the safety and efficacy of pharmacotherapy has traditionally relied upon changes in scale weight, ignoring measures of body composition changes, such as in body fat and fat-free mass (FFM). No FDA studies reported changes in body composition during the approval process for fenfluramine and dexfenfluramine, nor were any body composition studies reviewed in an article by the National Task Force on the Prevention and Treatment of Obesity on the safety and efficacy of long-term pharmacotherapy to manage obesity. Changes in scale weight can distort and obscure both positive and negative changes that occur in fat and FFM, which constitute an important screen for the safety and efficacy of a weight loss program. Furthermore, using loss of scale weight as the outcome criterion for weight loss programs can discourage the use of a behavior modification plan that affects scale weight losses through preservation of FFM. This study examined this potential source of bias and the extent to which integration of a behavior modification plan (which includes increased physical activity, improved dietary intake, and phytochemical glyconutritional dietary supplements) may improve the safety and efficacy of pharmacotherapy. Dual-energy x-ray absorptiometry measurements of body composition were performed in three groups of patients before and after a 60-day treatment period. Results of the study demonstrate that, although pharmacotherapy effected a significant reduction in scale weight, much of the loss was at the expense of FFM with no improvement in body composition. Conversely, the use of nutritional supplements and a behavior modification plan led to a preservation of FFM and significant improvement in body composition. In view of the widespread disregard of behavior modification programs in weight loss treatment plans that incorporate pharmacotherapy, these results offer another perspective on the success or failure of a weight loss program.
引用
收藏
页码:167 / 179
页数:13
相关论文
共 50 条
  • [41] Dietary Supplements: Safety Issues and Quality Control Reply
    McBride, Brian F.
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (05) : 477 - 477
  • [42] The Romanian consumers' perception regarding the safety of dietary supplements
    Burca, Valentin
    Csorba, Luiela Magdalena
    Munteanu, Florentina-Daniela
    Rusu, Sergiu
    JOURNAL OF PUBLIC HEALTH-HEIDELBERG, 2022, 30 (06): : 1583 - 1602
  • [43] Drug safety - IOM recommends action on dietary supplements
    Stokstad, E
    SCIENCE, 2004, 304 (5668) : 188 - 188
  • [44] The Romanian consumers’ perception regarding the safety of dietary supplements
    Valentin Burcă
    Luiela Magdalena Csorba
    Florentina-Daniela Munteanu
    Sergiu Rusu
    Journal of Public Health, 2022, 30 : 1583 - 1602
  • [45] FDA statutory authority to regulate the safety of dietary supplements
    Hutt, PB
    AMERICAN JOURNAL OF LAW & MEDICINE, 2005, 31 (2-3) : 155 - 174
  • [46] Injecting Safety into Supplements - Modernizing the Dietary Supplement Law
    Cohen, Pieter A.
    Bass, Scott
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (25): : 2387 - 2389
  • [47] Leveraging corporate social responsibility to improve consumer safety of dietary supplements sold for weight loss and muscle building
    Kulkarni, Anvita
    Huerto, Ryan
    Roberto, Christina A.
    Austin, Bryn
    TRANSLATIONAL BEHAVIORAL MEDICINE, 2017, 7 (01) : 92 - 97
  • [48] Evidence of Clinically Relevant Efficacy for Dietary Supplements and Nutraceuticals
    Arrigo F. G. Cicero
    Claudio Borghi
    Current Hypertension Reports, 2013, 15 : 260 - 267
  • [49] Evidence of Clinically Relevant Efficacy for Dietary Supplements and Nutraceuticals
    Cicero, Arrigo F. G.
    Borghi, Claudio
    CURRENT HYPERTENSION REPORTS, 2013, 15 (03) : 260 - 267
  • [50] Modification of surface pretreatment of white spot lesions to improve the safety and efficacy of resin infiltration
    Yim, Hyun-Kyung
    Min, Ji-Hyun
    Kwon, Ho-Keun
    Kim, Baek-Il
    KOREAN JOURNAL OF ORTHODONTICS, 2014, 44 (04) : 195 - 202